BB Biotech AG 2025 Annual Report with Sustainability Disclosures
Company: BB Biotech AG
Sector: Finance & insurance
Country: Switzerland
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 130
The report highlights BB Biotech's portfolio progress in 2025, including new approvals for medicines from Vertex, Argenx, Alnylam and Ionis. It also reports a 50% female Board, positive investment contributions to six UN SDGs, and the company's re-inclusion in the SPI ESG Index while its MSCI ESG A rating was confirmed.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.